Table 1.

The dose of DOTAP, GP100 peptide and CpG adjuvant administered into the mouse with different formulations. Treatment groups were Peptide+CpG, Lip-peptide, and Lip-peptide+CpG

Treatment groups	Formulation	Particle Size (nm)	PdI	Zeta potential (mV)
Peptide + CpG	GP100 + CpG	166.7 ± 5.42	0.287 ± 0.10	- 6.42 ± 0.00
Lip-peptide	DOTAP: Chol: GP100	231.5 ± 3.04	0.315 ± 0.01	6.15 ± 3.09
Lip-peptide + CpG	DOTAP: Chol: GP100 + CpG	277.7 ± 3.83	0.226 ± 0.06	-3.76 ± 6.14